Justin D. Westenberg

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer

A. Jager, R. Mathijssen, P. de Bruijn, 2021, Clinical Pharmacokinetics.

Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial

A. Jager, R. Mathijssen, R. V. van Schaik, 2022, Breast Cancer Research and Treatment.

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands.

A. Jager, R. Mathijssen, C. U. Uyl‐de Groot, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.